PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F0Z21
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $122,644
Award facts
- Contract value 100% obligated
- $122,644.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 19, 2026, represents a $122.6K firm fixed-price purchase from Amerisourcebergen Drug Corp (CAGE 0U9U0), a subsidiary of Cencora, Inc., for pharmaceutical and medical supplies to support federal military healthcare operations. The contract is non-set-aside and competitively awarded, with performance completion targeted for January 20, 2026, and fulfillment occurring at the awardee's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated as SPE2DX and valued at $999.9M through December 2026. This prime pharmaceutical supply vehicle enables the company to deliver a comprehensive range of medications, medical devices, vaccines, and specialized healthcare commodities to support military treatment facilities and veteran healthcare systems globally.
The Defense Logistics Agency's Medical Supply Chain, the funding federal agency, relies on this pharmaceutical prime vendor arrangement to ensure consistent access to critical medications across multiple therapeutic domains, including specialty drugs, generic and brand-name pharmaceuticals, and medical supplies. Cencora, Inc., the parent company, holds an even larger IDC with DLA Troop Support Medical valued at $999.9M through December 2031, reflecting the company's significant role as a strategic pharmaceutical distributor for Department of Defense healthcare programs. The non-set-aside competitive award status demonstrates Amerisourcebergen Drug Corp's capability to meet federal procurement standards in open competition against other qualified pharmaceutical vendors.
Quick answers
Who was awarded contract SPE2D826F0Z21?
SPE2D826F0Z21 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826F0Z21 worth?
The government has obligated $122,644 on SPE2D826F0Z21.
Is contract SPE2D826F0Z21 an order under another contract?
Yes. SPE2D826F0Z21 is a delivery order under SPE2DX22D0089, an indefinite delivery contract.
Was contract SPE2D826F0Z21 competed?
The extent of competition for SPE2D826F0Z21 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award